Skip to content

H.R. 2319 · 119th Congress (2025–2027)

Women and Lung Cancer Research and Preventive Services Act of 2025

This bill requires the Department of Health and Human Services to conduct an interagency review to accelerate lung cancer research, prevention, and awareness with respect to women and underserved populations.

The review must

  • report on the status of existing research and current knowledge gaps;
  • identify new opportunities for collaborative research to determine the causes of lung cancer and advance prevention, screening, diagnosis, and treatment; and
  • provide recommendations for a national lung cancer screening strategy and public education campaign.
Show official title

To direct the Secretary of Health and Human Services to conduct a review to evaluate the status of research on lung cancer in women and underserved populations, and for other purposes.

Passed House

This bill’s path

392 days after it was introduced

This is H.R. 2319’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced13 months

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

Sponsor
Rep. Brendan F. Boyle (D-PA-2)
Cosponsors
2 cosponsors

0 original · 2 later

  1. Rep. Brian K. Fitzpatrick (R-PA-1)· Later · Mar 31, 2025
  2. Rep. Juan Ciscomani (R-AZ-6)· Later · Sep 15, 2025
Policy area
Health
Subjects
  • Cancer
  • Cardiovascular and respiratory health
  • Government studies and investigations
  • Health care coverage and access
  • Health promotion and preventive care
  • Medical research
  • Medical tests and diagnostic methods
  • Women's health

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. ▸ 4 committee actions · Mar 25, 2025 – Nov 18, 2025
    1. Referred to committee

      Referred to the House Committee on Energy and Commerce.

      Sources
    2. Markup session held

      Committee Consideration and Mark-up Session Held

      Sources
    3. Ordered reported

      Ordered to be Reported by Voice Vote.

      Sources
    4. Reported by committee

      Reported by the Committee on Energy and Commerce. H. Rept. 119-382.

      Sources
  3. Latest

    Passed House

    Congressional Record H3020

    On motion to suspend the rules and pass the bill Agreed to by voice vote.

    The House passed the bill.

    Document: Engrossed in House

    Sources

Committees

  1. HouseEnergy and CommerceReferred Mar 25, 2025 · Markup Apr 29, 2025 · Reported Nov 19, 2025H. Rept. 119-382
    1. Apr 29, 2025 · Markup

    2. Apr 8, 2025 · Markup

    1. H. Rept. 119-382 · Nov 18, 2025 · Women and Lung Cancer Research and Preventive Services Act of 2025

Floor record

i

Explicit consideration evidence: the measure’s bill-status citation matched a GovInfo title, headline, or first paragraph. Incidental mentions are not listed.

  1. Apr 21, 2026 · House · Considered under suspension of the rulesCongressional Record H3020–H3021

    Women and Lung Cancer Research and Preventive Services Act of 2025

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Reported in House
Engrossed in House
Placed on Calendar Senate
Titles (2)
  1. Women and Lung Cancer Research and Preventive Services Act of 2025

    Display title, Short title · Placed on Calendar Senate, Engrossed in House, Reported in House, Introduced in House

  2. To direct the Secretary of Health and Human Services to conduct a review to evaluate the status of research on lung cancer in women and underserved populations, and for other purposes.

    Official title · Engrossed in House, Introduced in House